Page 77 - Read Online

Zlatkina et al. Vessel Plus 2019;3:7 I http://dx.doi.org/10.20517/2574-1209.2019.03 Page 11 of 11

43. Zhou YP, Grill V. Long-term exposure to fatty acids and ketones inhibits β-cell functions in human pancreatic islets of Langerhans. J
ClinEndocrinol. Metab 1995;80:1584-90.
44. Mason TM, Goh T, Tchipashvili V, Sandhu H, Gupta N, et al. Prolonged elevation of plasma free fatty acids desensitizes the insulin
secretory response to glucose in vivo in rats. Diabetes 1999;48:524-30.
45. Paolisso G, Gambardella A, Amato L, Tortoriello R, D’Amore A, et al. Opposite effects of short- and long-term fatty acid infusion on
insulin secretion in healthy subjects. Diabetologia 1995;38:1295-9.
46. Liu YQ, Tornheim K, Leahy JL. Fatty-acid induced β-cell hypersensitivity to glucose. Increased phosphofructokinase activity and
lowered glucose-6-phosphate content. J Clin Invest 1998;101:1870-5.
47. Magnan C, Collins S, Berthault MF, Kassis N, Vincent M, et al. Lipid infusion lowers sympathetic nervous activity and leads to
increased β-cell responsiveness to glucose. J Clin Invest 1999;103:413-9.
48. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link
between obesity, β-cell dysfunction, and type 2 diabetes. Cell 2001;105:745-55.
49. Joseph JW, Koshkin V, Zhang CY, Wang J, Lowell BB, et al. Uncoupling protein 2 knockout mice have enhanced insulin secretory
capacity after a high-fat diet. Diabetes 2002;51:3211-9.
50. Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F. Uncoupling protein 2: a possible link between fatty acid excess and
impaired glucose-induced insulin secretion? Diabetes 2001;50:803-9.
51. Medvedev AV, Robidoux J, Bai X, Cao W, Floering LM, et al. Regulation of the uncoupling protein-2 gene in INS-1 β-cells by oleic
acid. J BiolChem 2002;277:42639-44.
52. Medvedev AV, Snedden SK, Raimbault S, Ricquier D, Collins S. Transcriptional regulation of the mouse uncoupling protein-2 gene.
Double E-box motif is required for peroxisome proliferator-activated receptor- -dependent activation. J BiolChem 2001;276:10817-23.
53. Roche E, Farfari S, Witters LA, Assimacopoulos-Jeannet F, Thumelin S, et al. Long-term exposure of β-INS cells to high glucose
concentrations increases anaplerosis, lipogenesis, andlipogenic gene expression. Diabetes 1998;47:1086-94.
54. Ruderman N, Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov
2004;3:340-51.
55. Wang X, Zhou L, Li G, Luo T, Gu Y, et al. Palmitate activates AMP-activated protein kinase and regulates insulin secretion from β cells.
Biochem Biophys Res Commun 2007;352:463-8.
56. Brøns C, Vaag A. Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes. J Physiol 2009;587:3977-8.
57. Dalle S. Diabetes: what are the key targets and the objectives? Preserving and protecting a functional pancreatic beta cell mass. Biol
Aujourdhui 2017;211:165-8. (in French)